Pharma Key drugs Repatha, Aimovig flail as cheap copies eat into Amgen sales
Roche dominates 2019’s big patent expirations
Pharm Exec's 2019 Pipeline Report
Angst about Aimovig pickup and reimbursement overshadows Amgen’s solid quarter
7 drugmakers to watch on Q3 earnings
Moody's picks 5 early winners in biosimilar market
Mylan Strikes $463 Million Deal With Novartis for CF Product Line
2018 is already half over, but expect fireworks now that President Trump has turned his attention to seeking lower drug prices. The Tweeter-in-Chief publicly shamed companies that have tried to take the typical mid-year price increases. Without the usual bump in price, some companies are going to face stagnate growth to some of their biggest … Συνεχίστε να διαβάζετε 7 companies to watch during Q2 earnings.